132 related articles for article (PubMed ID: 31481305)
1. Effective plasma concentrations of itraconazole and its active metabolite for the treatment of pulmonary aspergillosis.
Nakamura Y; Matsumoto K; Sato A; Morita K
J Infect Chemother; 2020 Feb; 26(2):170-174. PubMed ID: 31481305
[TBL] [Abstract][Full Text] [Related]
2. [Two cases of pulmonary aspergilosis, which deteriorated with generic itraconazole].
Saito W; Shishikura Y; Nishimaki K; Kikuchi T; Sasamori K; Kikuchi Y; Miki H
Kansenshogaku Zasshi; 2014 Jul; 88(4):469-73. PubMed ID: 25199382
[TBL] [Abstract][Full Text] [Related]
3. Serum itraconazole and hydroxyitraconazole concentrations and interaction with digoxin in a case of chronic hypertrophic pachymenigitis caused by Aspergillus flavus.
Mochizuki M; Murase S; Takahashi K; Shimada S; Kume H; Iizuka T; Fukuda M
Nihon Ishinkin Gakkai Zasshi; 2000; 41(1):33-9. PubMed ID: 10660641
[TBL] [Abstract][Full Text] [Related]
4. [An open, noncomparative multicenter study of the efficacy and safety of itraconazole injections and high dose capsules in chronic pulmonary aspergillosis].
Tomioka H; Kaneda T; Kida Y; Kaneko M; Fujii H; Hayashi M; Tomii K; Tada K; Suzuki Y; Karino T
Kansenshogaku Zasshi; 2011 Nov; 85(6):644-51. PubMed ID: 22250455
[TBL] [Abstract][Full Text] [Related]
5. [Correlations between drug plasma concentration and adverse effects in patients treated with itraconazole for pulmonary aspergilloma].
Maesaki S; Hashiguchi K; Tomiyama Y; Sasaki E; Miyazaki H; Miyazaki Y; Higashiyama Y; Tomono K; Tashiro T; Kohno S
Nihon Kokyuki Gakkai Zasshi; 1999 Nov; 37(11):875-9. PubMed ID: 18217308
[TBL] [Abstract][Full Text] [Related]
6. Plasma Concentration of Itraconazole in Patients With Hematologic Malignancies Treated With Itraconazole Oral Solution.
Marumo A; Miyawaki S; Dan N; Ishiyama K
Ther Drug Monit; 2017 Jun; 39(3):229-234. PubMed ID: 28445212
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of short- and long-term treatment of itraconazole on chronic necrotizing pulmonary aspergillosis in multicenter study.
Yoshida K; Kurashima A; Kamei K; Oritsu M; Ando T; Yamamoto T; Niki Y
J Infect Chemother; 2012 Jun; 18(3):378-85. PubMed ID: 22526387
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of measuring the blood concentration of itraconazole oral solution in the field of hematology.
Shimoeda S; Nakagawa S; Kobayashi H; Yamato S; Kawano K; Ohta S
Biol Pharm Bull; 2010; 33(11):1861-6. PubMed ID: 21048312
[TBL] [Abstract][Full Text] [Related]
9. Effect of Itraconazole and Its Metabolite Hydroxyitraconazole on the Blood Concentrations of Cyclosporine and Tacrolimus in Lung Transplant Recipients.
Matsuda Y; Nakagawa S; Yano I; Masuda S; Imai S; Yonezawa A; Yamamoto T; Sugimoto M; Tsuda M; Tsuzuki T; Omura T; Nakagawa T; Chen-Yoshikawa TF; Nagao M; Date H; Matsubara K
Biol Pharm Bull; 2022; 45(4):397-402. PubMed ID: 35370263
[TBL] [Abstract][Full Text] [Related]
10. Comparison of long-term and short-term administration of itraconazole for primary antifungal prophylaxis in recipients of allogeneic hematopoietic stem cell transplantation: a multicenter, randomized, open-label trial.
Lin R; Xu X; Li Y; Sun J; Fan Z; Jiang Q; Huang F; Zhou H; Nie D; Guo Z; Mao Y; Xiao Y; Liu Q
Transpl Infect Dis; 2014 Apr; 16(2):286-94. PubMed ID: 24593273
[TBL] [Abstract][Full Text] [Related]
11. [Influence of black vinegar on itraconazole absorption].
Oguma T; Tabata H; Aihara K; Matsumoto M; Kagioka H; Nagano M; Fukui M
Kansenshogaku Zasshi; 2009 Jul; 83(4):369-74. PubMed ID: 19697872
[TBL] [Abstract][Full Text] [Related]
12. Measurement of posaconazole, itraconazole, and hydroxyitraconazole in plasma/serum by high-performance liquid chromatography with fluorescence detection.
Buckner SL; Ceesay MM; Pagliuca A; Morgan PE; Flanagan RJ
Ther Drug Monit; 2011 Dec; 33(6):735-41. PubMed ID: 22105591
[TBL] [Abstract][Full Text] [Related]
13. [A case of pulmonary aspergilloma successfully treated with transbronchial intracavitary itraconazole].
Tani S; Tomioka H; Tsuchimoto K; Kaneda T; Kubota M; Kaneko M; Fujii H
Nihon Kokyuki Gakkai Zasshi; 2008 Dec; 46(12):997-1002. PubMed ID: 19195200
[TBL] [Abstract][Full Text] [Related]
14. [Significance of monitoring trough plasma concentration levels for invasive fungal infection prophylaxis with itraconazole oral solution in patients with hematological malignancies: a prospective study].
Kawano I; Matsumoto K; Jiromaru T; Jinnochi F; Semba Y; Sugio T; Sakamoto K; Saito N; Yoshida S; Henzan H; Takase K; Morita K; Eto T
Rinsho Ketsueki; 2016; 57(12):2475-2480. PubMed ID: 28090013
[TBL] [Abstract][Full Text] [Related]
15. Sensitive and selective quantification of total and free itraconazole and hydroxyitraconazole in human plasma using ultra-performance liquid chromatography coupled to tandem mass spectrometry.
Suzuki Y; Tanaka R; Oyama N; Nonoshita K; Hashinaga K; Umeki K; Sato Y; Hiramatsu K; Kadota JI; Itoh H
Clin Biochem; 2017 Dec; 50(18):1228-1236. PubMed ID: 28928005
[TBL] [Abstract][Full Text] [Related]
16. Marked intra- and inter-patient variability of itraconazole steady state plasma concentrations.
Poirier JM; Berlioz F; Isnard F; Cheymol G
Therapie; 1996; 51(2):163-7. PubMed ID: 8763051
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic investigation of oral itraconazole in stratum corneum level of tinea pedis.
Morimoto K; Tanuma H; Kikuchi I; Kusunoki T; Kawana S
Mycoses; 2004 Apr; 47(3-4):104-14. PubMed ID: 15078426
[TBL] [Abstract][Full Text] [Related]
18. [Development of treatment adherence by jellification of itraconazole oral solution].
Wada H; Tanabe S; Ichikawa K; Sano F; Kubo Y; Matsuhashi Y; Nakanishi H; Tasaka T; Sugihara T
Jpn J Antibiot; 2009 Feb; 62(1):17-25. PubMed ID: 19378767
[TBL] [Abstract][Full Text] [Related]
19. Intravenous itraconazole followed by oral itraconazole for the treatment of amphotericin-B-refractory invasive pulmonary aspergillosis.
Caillot D
Acta Haematol; 2003; 109(3):111-8. PubMed ID: 12714819
[TBL] [Abstract][Full Text] [Related]
20. Plasma itraconazole concentrations in patients with neutropenia: advantages of a divided daily dosage regimen.
Poirier JM; Hardy S; Isnard F; Tilleul P; Weissenburger J; Cheymol G
Ther Drug Monit; 1997 Oct; 19(5):525-9. PubMed ID: 9357095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]